385 related articles for article (PubMed ID: 23503527)
1. Targeting Toll-like receptors with small molecule agents.
Wang X; Smith C; Yin H
Chem Soc Rev; 2013 Jun; 42(12):4859-66. PubMed ID: 23503527
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Modulators of Toll-like Receptors.
Wang Y; Zhang S; Li H; Wang H; Zhang T; Hutchinson MR; Yin H; Wang X
Acc Chem Res; 2020 May; 53(5):1046-1055. PubMed ID: 32233400
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists.
Keshavarz A; Pourbagheri-Sigaroodi A; Zafari P; Bagheri N; Ghaffari SH; Bashash D
IUBMB Life; 2021 Jan; 73(1):10-25. PubMed ID: 33217774
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in the development of Toll-like receptor (TLR) antagonists.
Patra MC; Choi S
Expert Opin Ther Pat; 2016 Jun; 26(6):719-30. PubMed ID: 27136061
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists.
Federico S; Pozzetti L; Papa A; Carullo G; Gemma S; Butini S; Campiani G; Relitti N
J Med Chem; 2020 Nov; 63(22):13466-13513. PubMed ID: 32845153
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors: promising therapeutic targets for inflammatory diseases.
Achek A; Yesudhas D; Choi S
Arch Pharm Res; 2016 Aug; 39(8):1032-49. PubMed ID: 27515048
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors in human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
[TBL] [Abstract][Full Text] [Related]
8. Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics.
Gomariz RP; Gutiérrez-Cañas I; Arranz A; Carrión M; Juarranz Y; Leceta J; Martínez C
Curr Pharm Des; 2010; 16(9):1063-80. PubMed ID: 20030612
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of toll-like receptors in gastrointestinal inflammation.
Ishihara S; Rumi MA; Ortega-Cava CF; Kazumori H; Kadowaki Y; Ishimura N; Kinoshita Y
Curr Pharm Des; 2006; 12(32):4215-28. PubMed ID: 17100624
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of microRNAs in the regulation of Toll-like receptor (TLR)-signaling.
Banerjee S; Thompson WE; Chowdhury I
Front Biosci (Landmark Ed); 2021 Jan; 26(4):771-796. PubMed ID: 33049693
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor signaling in parasitic infections.
Ashour DS
Expert Rev Clin Immunol; 2015 Jun; 11(6):771-80. PubMed ID: 25896399
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
Ma Z; Zhang E; Yang D; Lu M
Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
[TBL] [Abstract][Full Text] [Related]
13. The application of Toll like receptors for cancer therapy.
So EY; Ouchi T
Int J Biol Sci; 2010 Nov; 6(7):675-81. PubMed ID: 21060729
[TBL] [Abstract][Full Text] [Related]
14. Role of toll-like receptors in inflammatory bowel disease.
Kordjazy N; Haj-Mirzaian A; Haj-Mirzaian A; Rohani MM; Gelfand EW; Rezaei N; Abdolghaffari AH
Pharmacol Res; 2018 Mar; 129():204-215. PubMed ID: 29155256
[TBL] [Abstract][Full Text] [Related]
15. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.
Khajeh Alizadeh Attar M; Anwar MA; Eskian M; Keshavarz-Fathi M; Choi S; Rezaei N
Med Res Rev; 2018 Sep; 38(5):1469-1484. PubMed ID: 29283184
[TBL] [Abstract][Full Text] [Related]
16. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives.
Mukherjee S; Patra R; Behzadi P; Masotti A; Paolini A; Sarshar M
Front Immunol; 2023; 14():1244345. PubMed ID: 37822929
[TBL] [Abstract][Full Text] [Related]
18. Targeting Toll like Receptors in Cancer: Role of TLR Natural and Synthetic Modulators.
Narayanankutty A; Sasidharan A; Job JT
Curr Pharm Des; 2020; 26(39):5040-5053. PubMed ID: 32693759
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.
Hanke ML; Kielian T
Clin Sci (Lond); 2011 Nov; 121(9):367-87. PubMed ID: 21745188
[TBL] [Abstract][Full Text] [Related]
20. Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics.
Wang J; Zhang J; Wang J; Hu X; Ouyang L; Wang Y
J Med Chem; 2023 May; 66(10):6437-6462. PubMed ID: 37163340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
